---
title: "IBA introduces AdaPTinsight XR, the next generation of CBCT imaging for image-guided proton therapy"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286200296.md"
description: "IBA has launched AdaPTinsight XR, an advanced CBCT imaging solution for proton therapy, enhancing image-guided patient positioning and treatment. This state-of-the-art technology aims to improve precision in cancer treatment, offering effective therapy with minimal side effects. The integration of this imaging solution within the Proteus® Portfolio reflects a commitment to better patient outcomes, marking a significant milestone in cancer treatment advancements."
datetime: "2026-05-13T05:01:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286200296.md)
  - [en](https://longbridge.com/en/news/286200296.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286200296.md)
---

# IBA introduces AdaPTinsight XR, the next generation of CBCT imaging for image-guided proton therapy

The latest addition to the Proton therapy CBCT imaging solution within the Proteus® Portfolio offers enhanced clarity and confidence in Image-Guided Patient Positioning and Treatment (IGPT). This advancement provides state-of-the-art technology for precise and targeted treatment delivery. Proton therapy, a cutting-edge form of radiation therapy, has proven to be effective in treating various cancers with minimal side effects. The implementation of CBCT imaging solution across the Proteus® Portfolio underscores the commitment to improving patient outcomes. With this advancement, healthcare providers can now access a comprehensive solution that integrates advanced imaging technology with proton therapy for enhanced precision. This development is a significant milestone in the field of cancer treatment, with the potential to benefit a large number of patients seeking advanced and effective therapy options.

### Related Stocks

- [BMR.US](https://longbridge.com/en/quote/BMR.US.md)
- [BEEM.US](https://longbridge.com/en/quote/BEEM.US.md)
- [BEAM.US](https://longbridge.com/en/quote/BEAM.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)

## Related News & Research

- [Beam Global GAAP EPS of -$0.33 misses by $0.12, revenue of $3.1M misses by $4.24M](https://longbridge.com/en/news/286616888.md)
- [US cancer clinics scramble to get experimental Revolution Medicines pancreatic cancer drug](https://longbridge.com/en/news/286394551.md)
- [Beamr to Present its ML-Safe Video Data Stack to AV Engineers at AutoSens USA | BMR Stock News](https://longbridge.com/en/news/287057657.md)
- [Beamr to present ML-safe video data stack at AutoSens USA conference](https://longbridge.com/en/news/287057833.md)
- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)